These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12794566)

  • 1. Assessing usual care in clinical trials of adherence interventions for highly active antiretroviral therapy.
    Wagner GJ; Kanouse DE
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):276-7. PubMed ID: 12794566
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence in clinical trials and in clinical practice.
    Walsh JC
    Antivir Ther; 1999; 4 Suppl 3():49-54. PubMed ID: 16021871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring adherence to antiretroviral medications in clinical trials.
    Miller LG; Hays RD
    HIV Clin Trials; 2000; 1(1):36-46. PubMed ID: 11590488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.
    de Bruin M; Viechtbauer W; Schaalma HP; Kok G; Abraham C; Hospers HJ
    Arch Intern Med; 2010 Feb; 170(3):240-50. PubMed ID: 20142568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence study recruiting.
    AIDS Patient Care STDS; 2001 Oct; 15(10):545. PubMed ID: 11689142
    [No Abstract]   [Full Text] [Related]  

  • 6. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.
    Mannheimer S; Friedland G; Matts J; Child C; Chesney M
    Clin Infect Dis; 2002 Apr; 34(8):1115-21. PubMed ID: 11915001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational interviewing for improving adherence to antiretroviral medications.
    Cooperman NA; Arnsten JH
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):159-64. PubMed ID: 16343372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.
    Simoni JM; Montgomery A; Martin E; New M; Demas PA; Rana S
    Pediatrics; 2007 Jun; 119(6):e1371-83. PubMed ID: 17533177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Rueda S; Park-Wyllie LY; Bayoumi AM; Tynan AM; Antoniou TA; Rourke SB; Glazier RH
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD001442. PubMed ID: 16855968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral adherence in a resource-poor setting.
    Orrell C
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):171-6. PubMed ID: 16343374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to improve adherence to antiretroviral therapy.
    Tuldrà A; Wu AW
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S154-7. PubMed ID: 12562041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic viability of antiretroviral adherence interventions.
    Bozzette SA; Gifford AL
    Am J Med; 2003 Dec; 115(8):672-3. PubMed ID: 14656623
    [No Abstract]   [Full Text] [Related]  

  • 13. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review.
    Mathes T; Pieper D; Antoine SL; Eikermann M
    HIV Med; 2013 Nov; 14(10):583-95. PubMed ID: 23773654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy.
    Gross R; Bilker WB; Friedman HM; Coyne JC; Strom BL
    AIDS; 2002 Sep; 16(13):1835-7. PubMed ID: 12218400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world.
    Popp D; Fisher JD
    AIDS; 2002 Mar; 16(4):676-8. PubMed ID: 11873017
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to highly active antiretroviral therapy.
    Low A; Markowitz M
    AIDS Read; 2006 Aug; 16(8):425-8, 430-1, 434, 436. PubMed ID: 16933376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life, satisfaction, adherence and effectivity to antiretroviral treatment].
    Knobel H
    Enferm Infecc Microbiol Clin; 2005 Dec; 23(10):579-80. PubMed ID: 16324545
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment: Factors affecting patient adherence to highly active antiretroviral therapy.
    Ngo C; Sansgiry SS
    Ann Pharmacother; 2004 Mar; 38(3):511; author reply 511. PubMed ID: 14755061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.